John Greenwood

Professor of Cardiology, Leeds Institute for Cardiovascular and Diabetes Research, United Kingdom

John Greenwood is a Professor of Cardiology in the Leeds Institute for Cardiovascular and Diabetes Research (LICAMM) and Consultant Cardiologist at Leeds Teaching Hospitals NHS Trust, where he specialises in Percutaneous Coronary Intervention (PCI) and Cardiovascular Magnetic Resonance (CMR) imaging.

He qualified in medicine from Leeds in 1991 and after general medical training in Yorkshire undertook a clinical PhD in Leeds, funded by the British Heart Foundation.

His main area of research is the diagnosis and treatment of stable and unstable coronary artery disease. In terms of diagnostics, this particularly involves the use of CMR in relation to its development and validation through clinical trials. He was Chief Investigator on the landmark CE-MARC study which compared the diagnostic accuracy (Lancet 2012), cost effectiveness (Heart 2013) and prognostic ability (Annals of Internal Medicine 2016) of CMR and MPS-SPECT against X-ray angiography. He was also Chief Investigator on the BHF funded CE-MARC 2 trial, a UK multi-centre, 3-way RCT comparing CMR vs. MPS-SPECT vs. UK NICE (CG95) guidelines for the management of patients with stable chest pain (JAMA 2016). In terms of therapeutics, he is collaborating on a number of major multi-centre clinical trials designed to improve outcomes in patients undergoing primary PCI for acute myocardial infarction.

He has been a longstanding Board member of BSCMR (British Society of Cardiovascular MR), including Treasurer and now President-Elect of the Society. In 2013 he was elected onto the British Cardiovascular Society (BCS) Scientific Programme Committee and in 2017 was elected as BCS Vice-President for Education & Research.

Professor Greenwood was the Clinical Lead for the supra-regional CMR service in Leeds (2006-2016), one of the UKs largest, and as an interventional cardiologist contributes to the coronary intervention service for West Yorkshire, including the regional primary PCI service. Since 2014 he has been Director of the Cardiovascular Clinical Research Facility at Leeds Teaching Hospitals NHS Trust.

Back to speakers